Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
crispr
deals
gene editing
life sciences
national blog main
san francisco blog main
abbvie
allergan
alzheimer's disease
biotech
clinical trials
cynthia collins
david walt
diagnostics
editas medicine
feng zhang
illumina
jennifer doudna
jim collins
leber congenital amaurosis type 10
mammoth biosciences
michelle robertson
national top stories
parkinson's disease
rare diseases
san francisco top stories
startups
the broad institute of mit and harvard
vc
voyager therapeutics
What
editing
2
×
gene
medicines
2
×
abbvie
alliance
bio
biotech
create
crispr
diagnostic
diseases
editas
exits
experimental
fix
genetic
heats
high
human
launches
pact
partnership
pruning
race
research
returning
rights
sherlock
stakes
technology
terminated
treatment
trials
underway
use
years
Language
unset
Current search:
boston
×
medicines
×
editing
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
